← Open Payments lookup

TIFFANY LEISTER: Open Payments

NPI 1629302823 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,923 in 131 payments from 19 companies in 2025. Trend: 2023 $2,347 · 2024 $2,570 · 2025 $2,923

Food & beverage: $2,923
CompanyPaymentsAmount
PFIZER INC.24$372
Abbott Laboratories14$336
Philips North America LLC16$317
E.R. Squibb & Sons, L.L.C.13$239
Bayer Healthcare Pharmaceuticals Inc.9$229
Alnylam Pharmaceuticals Inc.4$219
AstraZeneca Pharmaceuticals LP7$202
Amgen Inc.6$160
Novartis Pharmaceuticals Corporation4$156
Merck Sharp & Dohme LLC6$129

Products named: Ambulatory Monitoring & Diagnostics Undivided, CAMZYOS, Kerendia, AMVUTTRA, VYNDAQEL, AVEIR, ELIQUIS, Repatha.

Industry payments across MS — which companies pay providers there.